LivaNova PLC | Mutual Funds
Mutual Funds that own LivaNova PLC
Fidelity Small Cap Value Fund
1,224,651
2.52%
-246,000
4.68%
04/30/2018
Oppenheimer International Small Company Fund
1,195,190
2.46%
1,195,190
1.43%
02/28/2018
iShares Core S&P Mid Cap ETF
1,191,146
2.45%
960
0.3%
09/06/2018
iShares Russell 2000 ETF
1,022,258
2.1%
-546
0.26%
09/06/2018
T Rowe Price International Stock Fund
913,230
1.88%
-77,539
0.77%
06/30/2018
Fidelity International Discovery Fund
686,802
1.41%
-4,300
0.87%
07/31/2018
ASTON/Pictet International Fund
632,939
1.3%
-23,000
3.8%
06/29/2018
Templeton Institutional Funds - Foreign Equity Series
606,362
1.25%
606,362
1.93%
03/31/2018
Vanguard Extended Market Index Fund
577,429
1.19%
2,200
0.1%
07/31/2018
Oakmark Equity & Income Fund
566,782
1.17%
0
0.48%
06/30/2018
| Address |
20 Eastbourne Terrace
London Greater London W2 6LG
United Kingdom
|
|
Employees
|
- |
| Website |
http://www.livanova.com |
| Updated |
07/08/2019 |
| LivaNova Plc is a global medical technology company, which engages in the development and delivery of important therapeutic solutions for the benefit of patients, healthcare professionals and healthcare systems. It operates through the Cardiac Surgery and Neuromodulation, and Other Corporate segments. The Cardiac Surgery and Neuromodulation segment corresponds to the primary therapeutic areas. |
